Fig. 8
From: Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
Illustration of pifithrin-μ enhancing sorafenib efficacy by targeting mTOR/CREB1/SESN3 axis in liver cancer cells.
Fig. 8 | Cell Death & Disease
From: Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
Illustration of pifithrin-μ enhancing sorafenib efficacy by targeting mTOR/CREB1/SESN3 axis in liver cancer cells.
